74 related articles for article (PubMed ID: 790125)
1. [Evidence for the action of raubasine from a new formulation of Lamuran tablets].
Glocke M; Grübl M; Klein K; Teufel W
Med Klin; 1976 Sep; 71(38):1564-8. PubMed ID: 790125
[TBL] [Abstract][Full Text] [Related]
2. [Modification of cerebrovascular diseases through the oral administration of raubasine].
Klein K; Grübl M
Wien Med Wochenschr; 1974 Jun; 124(23):360-4. PubMed ID: 4599577
[No Abstract] [Full Text] [Related]
3. [Action of raubasine (new formulation) in arterial occlusive diseases (author's transl)].
Schütz RM; Teufel W; Glocke M
Med Klin; 1976 Sep; 71(39):1605-10. PubMed ID: 790128
[TBL] [Abstract][Full Text] [Related]
4. [The cerebral blood-flow-volume in patients with sclerotic changes after treatment with raubasin (Lamuran)].
Klemm J; Scheuring HJ
Med Klin; 1974 May; 69(21):947-52. PubMed ID: 4602944
[No Abstract] [Full Text] [Related]
5. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
6. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo].
Rapisarda V; Azzaro E; Fichera G
Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827
[TBL] [Abstract][Full Text] [Related]
7. Carotid endarterectomy improves cerebrovascular reserve capacity preferentially in patients with preoperative impairment as indicated by asymmetric BOLD response to hypercapnia.
Goode SD; Altaf N; Auer DP; MacSweeney ST
Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):546-51. PubMed ID: 19744868
[TBL] [Abstract][Full Text] [Related]
8. Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine.
Sebban C
Eur Neurol; 1995; 35 Suppl 1():37-42. PubMed ID: 8529728
[No Abstract] [Full Text] [Related]
9. Yohimbine and the model anxiety state.
Henauer SA; Gillespie HK; Hollister LE
J Clin Psychiatry; 1984 Dec; 45(12):512-5. PubMed ID: 6501237
[TBL] [Abstract][Full Text] [Related]
10. [Antinoradrenergic activity of raubasine on isolated thoracic aorta and vas deferens of rat (author's transl)].
Roquebert J; Gomond P; Demichel P
J Pharmacol; 1981; 12(4):393-403. PubMed ID: 6119400
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.
Li S; Long J; Ma Z; Xu Z; Li J; Zhang Z
Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
Otomo E; Araki G; Mori A; Kurihara M
Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
Bargheon J; Durocher AM; Lagrange M
Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of papaverine plus raubasine in peripheral arterial insufficiency.
Brevetti G; Chiariello M; Verrienti S; Spena M; Desiderati M; Condorelli M
Angiology; 1983 Aug; 34(8):517-26. PubMed ID: 6614583
[TBL] [Abstract][Full Text] [Related]
15. Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial.
van de Wal HJ; Wijn PF; van Lier HJ; Skotnicki SH
Microcirc Endothelium Lymphatics; 1985; 2(6):657-85. PubMed ID: 2942753
[TBL] [Abstract][Full Text] [Related]
16. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs.
Cahn R; Cahn J
Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
Carbonin PU; Greco A; Pisanti P; Gemma A; Cattelin F
Clin Neuropharmacol; 1990; 13 Suppl 3():S92-9. PubMed ID: 2093422
[TBL] [Abstract][Full Text] [Related]
18. [Differential inhibition of raubasine and tetrahydroalstonine on the vasopressor response to sympathetic nervous stimulation and intravenous noradrenaline in the pithed rat].
Roquebert J; Demichel P; Dufour P
J Pharmacol; 1985; 16(4):412-20. PubMed ID: 2869187
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of cerebral circulatory insufficiency. Double-blind study of the efficacy of a quinine-papaverine combination].
Klemm J
Fortschr Med; 1984 Oct; 102(39):1000-2. PubMed ID: 6389288
[TBL] [Abstract][Full Text] [Related]
20. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
